BioAlliance Adds biothink(R) Network To Benefit Program; biothink Momentum And Subscription Base Growing

ROCKVILLE, Md., Dec. 4 /PRNewswire/ -- biosciences(R) Corporation and the Technology Council of Maryland (TCM) announced today an agreement that will provide marketing support of biosciences Corporation’s lead product, biothink. biothink -- a proprietary internet based solution to accelerate clinical research and medical product development projects -- will become part of the BioAlliance member benefit program and be marketed broadly to the regional biotech community. biothink will be supported in its marketing effort in a five state Mid-Atlantic region by Maryland BioAlliance, the biotechnology network within TCM.

biothink(R) is the first independent network service allowing industry to “outsource the search” for expert knowledge in the biosciences. biothink(R) enables the knowledge and expertise of bioscience service providers (e.g. Clinical Investigators, Consultants and Clinical Research Organizations (CROs)) to be quickly and efficiently identified and matched with the needs of bioscience service customers (e.g. Biotech, Medical Device and Pharmaceutical companies) accelerating specific product development requirements.

“Access to knowledge resources in the biosciences is complicated, time consuming and expensive because of the highly diverse yet specialized market,” states biosciences Corporation President, Edward R. Gubish, PhD. “Conventional knowledge recruitment hinders the pace of product development. We are committed to providing services that will accelerate clinical research.”

Dyan Brasington, President of TCM stated, “Our members will have the opportunity to utilize the web-based biothink Network to connect with qualified and authenticated product development and clinical expertise.”

Matt Gardner, Director of Maryland BioAlliance, explained, “biothink provides our members access to a broader range of knowledge and expertise of bioscience service providers to more quickly and efficiently identify and finalize agreements with needed vendors and clinicians. Our relationship with biothink is yet another example of our member benefits program.”

About biosciences. biosciences Corporation is focused on meeting the needs for obtaining and outsourcing specific expertise in the $40 billion biopharmaceutical research and development market. biosciences Corporation provides consulting and management services from clinical research to product portfolio management. To learn more about biothink, go to http://www.biothink.com/.

About the Bioalliance. The Maryland Bioscience Alliance, also known as the BioAlliance, is a division of the Technology Council of Maryland (TCM). The BioAlliance is a statewide, non-profit membership organization dedicated to serving the needs of Maryland’s growing biotechnology community. As a state affiliate of the Biotechnology Industry Organization, the BioAlliance works synergistically with BIO to promote industry advocacy, facilitate group purchasing and provide critical networking. To learn more about TCM, go to http://www.mdhitech.org/.

Technology Council of Maryland

CONTACT: Michelle Ferrone, Communications Director of the TechnologyCouncil of Maryland, +1-240-453-6217

MORE ON THIS TOPIC